Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Rapoport

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Headache|June 6, 2009
Obesity and migraine: the effect of age, gender and adipose tissue distributionB Lee Peterlin, Andrea L Rosso, Alan M Rapoport, et al.
Current Therapeutic Research, Clinical and Experimental|March 28, 2014
Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot studyAlan M Rapoport, Fred D Sheftell, Stewart J Tepper, et al.
Headache|August 28, 2004
Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive casesStewart J Tepper, Marcelo E Bigal, Fred D Sheftell, et al.
Cephalalgia : an International Journal of Headache|November 28, 2015
Spontaneous extracranial hemorrhagic phenomena in primary headache disorders: A systematic review of published casesAddie M Peretz, Yohannes W Woldeamanuel, Alan M Rapoport, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Sumatriptan: a decade of use and experience in the treatment of migraineFred D Sheftell, Marcelo E Bigal, Stewart J Tepper, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Zolmitriptan (Zomig)Alan M Rapoport, Marcelo E Bigal, Stewart J Tepper, et al.
Headache|March 13, 2012
The association of obesity with episodic and chronic migraineRandolph W Evans, Michelle A Williams, Alan M Rapoport, et al.
CNS Drugs|May 16, 2006
Role of melatonin in the pathophysiology of migraine: implications for treatmentBarbara Vogler, Alan M Rapoport, Stewart J Tepper, et al.
CNS Drugs|October 7, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND StudyStewart J Tepper, Detlef Albrecht, Jessica Ailani, et al.
Headache|August 20, 2005
Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?Michel Volcy, Fred D Sheftell, Stewart J Tepper, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Headache|June 6, 2009
Obesity and migraine: the effect of age, gender and adipose tissue distributionB Lee Peterlin, Andrea L Rosso, Alan M Rapoport, et al.
Current Therapeutic Research, Clinical and Experimental|March 28, 2014
Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot studyAlan M Rapoport, Fred D Sheftell, Stewart J Tepper, et al.
Headache|August 28, 2004
Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive casesStewart J Tepper, Marcelo E Bigal, Fred D Sheftell, et al.
Cephalalgia : an International Journal of Headache|November 28, 2015
Spontaneous extracranial hemorrhagic phenomena in primary headache disorders: A systematic review of published casesAddie M Peretz, Yohannes W Woldeamanuel, Alan M Rapoport, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Sumatriptan: a decade of use and experience in the treatment of migraineFred D Sheftell, Marcelo E Bigal, Stewart J Tepper, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Zolmitriptan (Zomig)Alan M Rapoport, Marcelo E Bigal, Stewart J Tepper, et al.
Headache|March 13, 2012
The association of obesity with episodic and chronic migraineRandolph W Evans, Michelle A Williams, Alan M Rapoport, et al.
CNS Drugs|May 16, 2006
Role of melatonin in the pathophysiology of migraine: implications for treatmentBarbara Vogler, Alan M Rapoport, Stewart J Tepper, et al.
CNS Drugs|October 7, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND StudyStewart J Tepper, Detlef Albrecht, Jessica Ailani, et al.
Headache|August 20, 2005
Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?Michel Volcy, Fred D Sheftell, Stewart J Tepper, et al.
Pageof 12